                         SEQUENCE LISTING

<110>  VISBY MEDICAL, INC.
 
<120>  DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTIBILITY TESTING

<130>  VISB-010/02WO 323013-2066

<140>  PCT/US2019/049385
<141>  2019-09-03

<150>  US 62/820,359
<151>  2019-03-19

<150>  US 62/726,379
<151>  2018-09-03

<160>  23    

<170>  PatentIn version 3.5

<210>  1
<211>  2751
<212>  DNA
<213>  Niesseria gonorrhoeae

<400>  1
atgaccgacg caaccatccg ccacgaccac aaattcgccc tcgaaaccct gcccgtcagc       60

cttgaagacg aaatgcgcaa aagctatctc gactacgcca tgagcgtcat tgtcgggcgc      120

gcgctgccgg acgttcgcga cggcctaaag ccggtgcacc ggcgcgtact gtacgcgatg      180

cacgagctga aaaataactg gaatgccgcc tacaaaaaat cggcgcgcat cgtcggcgac      240

gtcatcggta aataccaccc ccacggcgat tccgcagttt acgacaccat cgtccgtatg      300

gcgcaaaatt tcgctatgcg ttatgtgctg atagacggac agggcaactt cggatcggtg      360

gacgggcttg ccgccgcagc catgcgctat accgaaatcc gcatggcgaa aatctcacat      420

gaaatgctgg cagacattga ggaagaaacc gttaatttcg gcccgaacta cgacggtagc      480

gaacacgagc cgcttgtact gccgacccgt ttccccacac tgctcgtcaa cggctcgtcc      540

ggtatcgccg tcggtatggc gaccaacatc ccgccgcaca acctcaccga caccatcaac      600

gcctgtctgc gtcttttgga cgaacccaaa accgaaatcg acgaactgat cgacattatc      660

caagcccccg acttcccgac cggggcaacc atctacggct tgggcggcgt gcgcgaaggc      720

tataaaacag gccgcggccg cgttgttatg cgcggtaaga cccatatcga acccataggc      780

aaaaacggcg aacgcgaacg catcgttatc gacgaaatcc cctatcaggt caacaaagcc      840

aagttggtcg agaaaatcgg cgatttggtt cgggaaaaaa cactggaagg catttccgag      900

ctccgcgacg aatccgacaa atccggtatg cgcgtcgtta tcgagctgaa acgcaacgaa      960

aatgccgaag tcgtcttaaa ccaactctac aaactgactc cgctgcaaga cagtttcggc     1020

atcaatatgg tggttttggt cgacggacaa ccgcgcctgt taaacctgaa acagattctc     1080

tccgaattcc tgcgccaccg ccgcgaagtc gttacccgac gtacgctttt ccggctgaag     1140

aaggcacgcc atgaagggca tatcgccgaa cggaaagccg tcgcactgtc caatatcgat     1200

gaaatcatca agctcatcaa agaatcgccc aacgcggccg aggccaaaga aaaactgctt     1260

gcgcgccctt gggccagcag cctcgttgaa gaaatgctga cgcgttccgg tctggatttg     1320

gaaatgatgc gtccggaagg attggtcgca aacattggtc tgaaaaaaca aggttattac     1380

ctgagcgaga ttcaggcaga tgctatttta cgcatgagcc tgcgaaacct gaccggcctc     1440

gatcagaaag aaattatcga aagctacaaa aacctgatgg gtaaaatcat cgactttgtg     1500

gatatcctct ccaaacccga acgcattacc caaatcatcc gtgacgaact ggaagaaatc     1560

aaaaccaact atggcgacga acgccgcagc gaaatcaacc cgttcggcgg cgacattgcc     1620

gatgaagacc tgattccgca acgcgaaatg gtcgtgaccc tgacccacgg cggctatata     1680

aaaacccagc cgaccaccga ctatcaggct cagcgtcgcg gcgggcgcgg caaacaggcg     1740

gctgccacca aagacgaaga ctttatcgaa accctgtttg ttgccaacac gcatgactat     1800

ttgatgtgtt ttaccaacct cggcaagtgc cactggatta aggtttacaa actgcccgaa     1860

ggcggacgca acagccgcgg ccgtccgatt aacaacgtca tccagctgga agaaggcgaa     1920

aaagtcagcg cgattctggc agtacgcgag tttcccgaag accaatacgt cttcttcgcc     1980

accgcgcagg gaatggtgaa aaaagtccaa ctttccgcct ttaaaaacgt ccgcgcccaa     2040

ggcattaaag ccatcgcact caaagaaggc gactacctcg tcggcgctgc gcaaacaggc     2100

ggtgcggacg acattatgtt gttctccaac ttgggcaaag ccatccgctt caacgaatac     2160

tgggaaaaat ccggcaacga cgaagcggaa gatgccgaca tcgaaaccga gatttcagac     2220

gacctcgaag acgaaaccgc cgacaacgaa aacaccctgc caagcggcaa aaacggcgtg     2280

cgtccgtccg gtcgcggcag cggcggtttg cgcggtatgc gcctgcctgc cgacggcaaa     2340

atcgtcagcc tgattacctt cgcccctgaa accgaagaaa gcggtttgca agttttaacc     2400

gccaccgcca acggatacgg aaaacgcacc ccgattgccg attacagccg caaaaacaaa     2460

ggcgggcaag gcagtattgc cattaacacc ggcgagcgca acggcgattt ggtcgccgca     2520

accttggtcg gcgaaaccga cgatttgatg ctgattacca gcggcggcgt gcttatccgt     2580

accaaagtcg aacaaatccg cgaaaccggc cgcgccgcag caggcgtgaa actgattaac     2640

ttggacgaag gcgaaacctt ggtatcgctg gaacgtgttg ccgaagacga atccgaactc     2700

tccggcgctt ctgtaatttc caatgtaacc gaaccggaag ccgagaactg a              2751


<210>  2
<211>  90
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Amplicon (AntiSense)

<400>  2
cgaaattttg cgccatacgg acgatggtgt cgtaaactgc ggaatcgccg tgggggtggt       60

atttaccgat gacgtcgccg acgatgcgcg                                        90


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Seq2 Reverse Primer

<400>  3
cgaaattttg cgccatacgg                                                   20


<210>  4
<211>  12
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Seq2 Forward Primer

<400>  4
gcgcatcgtc gg                                                           12


<210>  5
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe for Ciprofloxacin Susceptibility

<400>  5
cggtgattcc gcagt                                                        15


<210>  6
<211>  11
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GyrA Positive Control Probe

<400>  6
ataccacccc c                                                            11


<210>  7
<211>  108
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  gryA amplicon

<400>  7
cgcgcatcgt cggcgacgtc atcggtaaat accaccccca cggcgattcc gcagtttacg       60

acaccatcgt ccgtatggcg caaaatttcg ctatgcgtta tgtgctga                   108


<210>  8
<211>  11
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer

<400>  8
gcgcatcgtc g                                                            11


<210>  9
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  biotin conjugated to the reverse primer via a linker

<400>  9
tcagcacata acgcatagc                                                    19


<210>  10
<211>  108
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  gryA amplicon

<400>  10
cgcgcatcgt cggcgacgtc atcggtaaat accaccccca cggcgattcc gcagtttacg       60

acaccatcgt ccgtatggcg caaaatttcg ctatgcgtta tgtgctga                   108


<210>  11
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward Primer

<400>  11
cccccacggc gattcc                                                       16


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  biotin conjugated to the reverse primer via a linker

<400>  12
gatggtgtcg taaactgcgg a                                                 21


<210>  13
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer (reverse complement)

<400>  13
tccgcagttt acgacaccat c                                                 21


<210>  14
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 1


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  14
cggcgattcc gcagtt                                                       16


<210>  15
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 2


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  15
cggcgattcc gcagt                                                        15


<210>  16
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 3


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  16
cggtgattcc gcagt                                                        15


<210>  17
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 4


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  17
cggctattcc gcagt                                                        15


<210>  18
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 5


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  18
cggcgattcg gcagt                                                        15


<210>  19
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 7


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  19
cacggctatt ccgcagttt                                                    19


<210>  20
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 8


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amine-reactive moeity conjugated to the probe via a linker

<400>  20
tacggctatt ccgcagttt                                                    19


<210>  21
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse Primer


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  biotin conjugated to the reverse primer via a linker

<400>  21
gatggtgtcg taaactgcg                                                    19


<210>  22
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Control Probe

<400>  22
tcatcggtaa ataccacccc c                                                 21


<210>  23
<211>  68
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  gryA amplicon

<400>  23
cgcgcatcgt cggcgacgtc atcggtaaat accaccccca cggcgattcc gcagtttacg       60

acaccatc                                                                68


